AVANOS MEDICAL, INC.: operating_income
| Value | {"amount": 10400000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-12-31 |
| Status | superseded |
| Entity | AVANOS MEDICAL, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:28:35.851923+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/12542b1f-0853-4f96-9613-d856f3423461
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001606498-23-000020Retrieved: 2026-08-19T16:28:35.851923+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001606498/operating-income/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/12542b1f-0853-4f96-9613-d856f3423461
History
- supersedes {"amount": 8900000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} (evidence 0001606498-22-000029)